---  
layout: startup_page  
title: "Brise Pharmaceuticals Co"  
id: "brisepharma.com"  
permalink: "/brisepharmaceuticalscobrisepharma.com04222024/"  
website: "https://brisepharma.com/news.html"  
funding_round: "Pre Series A+"  
funding_amount: "$20M"  
investors: "Shunxi Fund, Cnfuel Capital, Vinner Therapeutics, Qiming Venture Partners, BioTrack Capital, Sherpa Healthcare Partners"  
about: "Brise Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative analgesic treatments for acute and chronic pain conditions like migraine, neuropathic, and musculoskeletal pain. They have advanced two molecules to the clinical stage and utilize a biology-based drug development platform targeting the Trigeminovascular System (TVS) and Dorsal Root Ganglion (DRG). Their mission is to provide safe, effective, and accessible pain relief solutions."  
markets: "Biotechnology, Pharmaceuticals, Pain Management"  
hq: "Shanghai, Shanghai, China"  
founded_year: "2021"  
linkedin: ""  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/brise-pharma"  
pitchbook: "https://pitchbook.com/profiles/company/490264-93"  

date_display: "22-Apr-2024"  
date: "2024-04-22"

# SEO Optimization  
meta_title: "Brise Pharmaceuticals Co - Pre Series A+ Funding ($20M)"  
meta_description: "Brise Pharmaceuticals Co, Brise Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative analgesic treatments for acute and chronic pain c..."  
meta_keywords: "Brise Pharmaceuticals Co, Biotechnology, Pharmaceuticals, Pain Management, Pre Series A+ funding"  
canonical_url: "https://startup.projectstartups.com/brisepharmaceuticalscobrisepharma.com04222024/"  
---